3-mercaptopropionic acid has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, XY; Ding, YT; Gao, ZX; Gu, JY; Li, YL; Ren, M; Shen, KJ; Wang, L; Wei, CY | 1 |
| Juzenas, P; Kavaliauskiene, S; Purviniene, R; Rotomskis, R; Steponkiene, S | 1 |
2 other study(ies) available for 3-mercaptopropionic acid and Malignant Melanoma
| Article | Year |
|---|---|
Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.
Topics: 3-Mercaptopropionic Acid; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Indoles; Melanoma; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sulfonamides; Vemurafenib | 2022 |
Quantum dots affect expression of CD133 surface antigen in melanoma cells.
Topics: 3-Mercaptopropionic Acid; AC133 Antigen; Antigens, CD; Biomarkers, Tumor; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Flow Cytometry; Glioblastoma; Glycoproteins; Humans; Hyaluronan Receptors; Male; Melanoma; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Phenotype; Prostatic Neoplasms; Quantum Dots; Tellurium | 2011 |